Xenon Pharmaceuticals (XENE) Outlines 2022 Key Milestones

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/1/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. DASH
9. MA
10. FND

Go back to Xenon Pharmaceuticals (XENE) Outlines 2022 Key Milestones

Xenon Pharmaceuticals Outlines Key Milestone Opportunities for 2022

January 10, 2022 8:30 AM EST

BURNABY, British Columbia, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neurology-focused biopharmaceutical company, today outlined its key milestones for 2022.

Mr. Ian Mortimer, Xenons President and Chief Executive Officer stated, We are entering 2022 with an immense amount of positive momentum, building upon the strong efficacy data from our XEN1101 Phase 2b X-TOLE clinical trial announced in the fourth quarter of 2021. We have set clear business objectives for 2022, with a... More